REGEN-αGEEK (SHENZHEN) MEDICAL TECHNOLOGY CO., LTD.

REGEN-αGEEK (SHENZHEN) MEDICAL TECHNOLOGY CO., LTD. is a company initiated from the scientific and technological achievements of the First Prize of the National Science and Technology Progress Award. Based on nearly two decades of clinical translational research on stem cells and regenerative medicine, the company mainly focuses on realizing the localized substitution of core raw materials and consumables for the cell and gene therapy industry, thus promoting the standardization and largescale application of cell and gene therapy. By building a DASEA bio-intelligence platform, the "5" goals ("Digitalized, Automated, Scalable, Enclosed, Activated") in manufacturing cells and exosomes realized, with which the one-stop solutions for cell culture and exosome manufacture can be afforded by hospitals, research institutes, and biotechnology companies who are carrying out therapeutic interventions based on cell and exosome.